儿科骨髓母细胞瘤的质子与光子辐射疗法:系统性审查和元分析
Lucca B Palavani1, Pedro G L B Borges2, Gabriel Semione3
1Max Planck University Center, Indaiatuba, São Paulo, Brazil.
概括
质子束辐射疗法 (PBRT) 和光子辐射疗法 (XRT) 显示小儿髓母细胞瘤的存活率相似. 与XRT相比,PBRT显著降低了轻微并发症的风险.
科学领域:
- 癌症学
- 辐射瘤学
- 儿童神经瘤学
背景情况:
- 放射治疗的进步改变了中枢神经系统癌症的治疗方法.
- 儿科骨髓母细胞瘤需要精确有效的治疗策略.
研究的目的:
- 在儿童脑髓母细胞瘤患者中,比较质子束辐射治疗 (PBRT) 与光子辐射治疗 (XRT) 的疗效和安全性.
- 分析PBRT和XRT之间的生存率和并发症概况的差异.
主要方法:
- 对1319项选研究进行了系统审查和比较元分析.
- 包括包括889名儿科患者的9个队列 (509名PBRT,380名XRT).
- 使用随机效应模型分析整体5年生存率和并发症.
主要成果:
- 在PBRT和XRT之间的5年整体存活率没有统计学意义上的差异 (OR0. 86).
- 在PBRT和XRT组中,主要并发症的发生率相似 (OR为0. 82).
- 在PBRT组中,轻微并发症的发生率明显低 (OR 0.11,p < 0.01).
结论:
- 与儿科骨髓母细胞瘤的光子辐射疗法相比,质子束辐射疗法 (PBRT) 与轻微并发症的发生率较低.
- PBRT的安全性和有效性与XRT相比,可能会降低对周围组织的辐射剂量.
更多相关视频
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.9K
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
9.6K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
